Artificial intelligence-enhanced wearable devices, such as continuous glucose monitors (CGMs), have dramatically improved the ability of people with diabetes and even prediabetes to better understand and control their blood sugar. But research on AI-enhanced wearable […]
Individuals with type 2 diabetes often have a higher incidence of tooth decay, but the underlying mechanisms remain unclear. Recent evidence indicates that hyperglycemia could lead to the overwhelming presence of sugars not only in […]
An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a microbial metabolite called trimethylamine (TMA). Published in Nature Metabolism, the study reveals that TMA, produced […]
For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic cough, according to a study published online Nov. 26 in JAMA Otolaryngology-Head & Neck Surgery.This […]
An international research team led by the Medical University of Vienna has shown that continuous glucose monitoring (CGM) in women with gestational diabetes can reduce the risk of a newborn with above-average birth weight. The […]
The risk of sudden cardiac death is higher for people with both type 1 and type 2 diabetes, according to a large study published in the European Heart Journal. The increase in risk is especially […]
While eye care and regular eye exams are important for everyone, they’re particularly vital for people with diabetes.This article was originally published on MedicalXpress.com
Imagine trying to enjoy your favorite meal but finding that your gums hurt, your mouth feels dry and chewing has become uncomfortable. For people living with diabetes, this can be a daily reality that often […]
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide (Ozempic) and liraglutide […]
A noninvasive method for measuring blood glucose levels, developed at MIT, could save diabetes patients from having to prick their fingers several times a day.This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca